Open AccessSuccessful rechallenge with cetuximab after progression with nivolumab for recurrent cervical lymph node metastasis from carcinoma of the tongue
Author(s) -
Asada Yasuyuki,
Teramura Chitoshi,
Wada Takuma,
Machida Yoshisato,
Koshinuma Shinya,
Yamamoto Gaku
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4464
Subject(s) - medicine , cetuximab , nivolumab , oncology , metastasis , lymph node metastasis , nasopharyngeal carcinoma , lymph node , cervical lymph nodes , immunotherapy , cancer , radiation therapy , colorectal cancer
We can infer that the immunostimulatory effect of nivolumab and reactivation of cetuximab enhance the antitumor effect of the therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom